Oracle Life Sciences InForm 7.0.1.0/7.0.1.1 App Server improper authorization

Summaryinfo

A vulnerability was found in Oracle Life Sciences InForm 7.0.1.0/7.0.1.1. It has been declared as critical. This issue affects some unknown processing of the component App Server. Executing a manipulation can lead to improper authorization. The identification of this vulnerability is CVE-2026-34324. The attack may be launched remotely. There is no exploit available. It is recommended to upgrade the affected component.

Detailsinfo

A vulnerability classified as critical was found in Oracle Life Sciences InForm 7.0.1.0/7.0.1.1. This vulnerability affects some unknown processing of the component App Server. The manipulation with an unknown input leads to a improper authorization vulnerability. The CWE definition for the vulnerability is CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

The advisory is available at oracle.com. This vulnerability was named CVE-2026-34324 since 03/26/2026. The exploitation appears to be easy. The attack can be initiated remotely. No form of authentication is required for a successful exploitation. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 04/22/2026). This vulnerability is assigned to T1548.002 by the MITRE ATT&CK project.

Upgrading eliminates this vulnerability.

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Productinfo

Vendor

• Oracle

Name

• Life Sciences InForm

Version

• 7.0.1.0
• 7.0.1.1

License

• commercial

Website

• Vendor: https://www.oracle.com

CPE 2.3info

• 🔒
• 🔒

CPE 2.2info

• 🔒
• 🔒

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Discussion